FINWIRES · TerminalLIVE
FINWIRES

CIBCはRBグローバルの投資判断を「アウトパフォーム」に据え置き、第1四半期決算を受けて目標株価を134米ドルに引き上げた。

By

-- CIBCキャピタル・マーケッツは、RBグローバル(RBA.TO、RBA)が月曜日に第1四半期決算を発表したことを受け、同社株の「アウトパフォーム」レーティングを維持し、目標株価を132ドルから134ドルに引き上げた。 CIBCは、「RBグローバルは第1四半期に好調な業績を上げ、市場予想を上回り、2026年度の業績見通しを引き上げた。また、事業運営と戦略的なM&A計画を着実に実行している」と指摘した。CIBCは、「両事業セグメントにおける一貫した実行力は、市場環境の変動性にもかかわらず、市場シェア拡大を継続できる基盤となっている」と評価している。 アナリストのクリスタ・フリーセン氏は、「マクロ経済および地政学的な不確実性は依然として残るものの、経営陣が市場シェア拡大、コスト管理、そして慎重な資本配分に注力していることから、同社の収益成長力に確信を持っている」と述べた。 CIBCは、第1四半期の決算が確定し、経営陣のコメントを反映させるため、モデルを修正した。同社は、2026年のEBITDAを従来予想の14億8000万米ドルから15億1000万米ドルに、2027年のEBITDAを従来予想の15億7000万米ドルから15億8000万米ドルに下方修正した。 (は、北米、アジア、ヨーロッパの主要銀行および調査会社による株式、商品、経済に関する調査レポートを配信しています。調査レポート提供者の方は、こちらからお問い合わせください:https://www..com/contact-us

Price: $145.67, Change: $+2.58, Percent Change: +1.80%

Related Articles

Australia

American Electric Power CEO Says Speed to Market Key Issue in Load Connection

American Electric Power (AEP) CEO Bill Fehrman said Tuesday that speed to market is the main issue in efficiently connecting energy load to generation.In a Q1 earnings call, Fehrman said that, in particular, the performance and stakeholder approval process of PJM, the US mid-Atlantic grid operator, represents a major challenge."The current state of PJM's performance and stakeholder approval process does not give me great confidence that these issues will be resolved any time soon," Fehrman said on the call."In fact, if something is not done now, I expect we could still be having these same conversations in 10 years," he added.Expanding and strengthening the grid will ensure new generation resources can connect quickly, reliably, and affordably to serve the growing load, the CEO said.Price: $137.27, Change: $+2.61, Percent Change: +1.94%

$AEP
Australia

MGE Energy Q1 Earnings, Revenue Rise

MGE Energy (MGEE) reported Q1 earnings Tuesday of $1.32 per diluted share, up from $1.14 a year earlier.One analyst polled by FactSet expected $1.13.Revenue for the three months ended March 31 was $242.7 million, up from $219 million a year earlier.Price: $80.48, Change: $+0.36, Percent Change: +0.46%

$MGEE
Research

Research Alert: CFRA Lowers Rating On Shares Of Pfizer Inc. To Hold From Buy

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target to $28 from $31, 9.4x our 2027 EPS estimate, below PFE's historical forward P/E average. We keep our 2026 EPS view at $2.99 and our 2027 EPS at $2.97. PFE delivered solid top- and bottom-line Q1 results today that exceeded expectations while demonstrating continued progress in its post-Covid transition strategy. While we continue to think that shares are trading at a discount, as the company's main focus in the next year is on AI integration, and a new transformative M&A is not a key priority, we see limited catalysts to drive meaningful upside potential. We think PFE is aiming to maximize value from launched and acquired products with particular focus on key areas: oncology, obesity/metabolic disease, and vaccines. PFE remains committed to maintaining its dividend, continuing productivity initiatives ($7.2B cost savings target), and pursuing targeted business development (with $7B capacity) but we do not expect PFE executing share buybacks to support the share price in the near term.

$PFE